The effect of immunoglobulinVH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

The effect of immunoglobulinVH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia

Published:2006 Issue:5 Volume:107 Page:1023-1033
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Francis Sebastian,Karanth Mamatha,Pratt Guy,Starczynski Jane,Hooper Laura,Fegan Chris,Pepper Chris,Valcarcel David,Milligan Donald W.,Delgado Julio

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference37 articles.

1. Chronic Lymphocytic Leukemia

2. Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL

3. Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia

4. ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia

5. Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first‐line chemoimmunotherapy;Cancer Medicine;2024-08

2. Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis;Annals of Hematology;2024-01-18

3. A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation;Expert Review of Hematology;2023-12-02

4. Infections in patients with chronic lymphocytic leukemia;Hematology, Transfusion and Cell Therapy;2023-07

5. SOHO State of the Art Updates and Next Questions | Infections in Chronic Lymphocytic Leukemia Patients: Risks and Management;Clinical Lymphoma Myeloma and Leukemia;2023-05